News | August 11, 2021
Marksons Pharma PAT at Rs 62.6 cr. for Q1FY22
The company has tied up with OrbiMed as a financial partner for global reach
The company has tied up with OrbiMed as a financial partner for global reach
Partnership enables broad reach of cfDNA methylation blood tests for early cancer detection
QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
The government has recently enhanced the incentive granted to storeowners from existing Rs. 2.50 lakh to Rs. 5.00 lakh given at the rate of 15% of monthly purchases made, subject to a ceiling of Rs. 15,000 per month
Filing for WHO Emergency Use Authorisation this month
The transaction is expected to close in the Q4FY22
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Subscribe To Our Newsletter & Stay Updated
